​

Bruker (BRKR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BRKR Stock Forecast

Bruker (BRKR) stock forecast, based on 32 Wall Street analysts, predicts a 12-month average price target of $49.71, with a high of $60.00 and a low of $40.00. This represents a 10.15% increase from the last price of $45.13.

$40 $51 $62 $73 $84 $95 High: $60 Avg: $49.71 Low: $40 Last Closed Price: $45.13

BRKR Stock Rating

Bruker stock's rating consensus is Hold, based on 32 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 15 Buy (46.88%), 16 Hold (50.00%), 1 Sell (3.12%), and 0 Strong Sell (0.00%).

Hold
Total 32 1 16 15 Strong Sell Sell Hold Buy Strong Buy

BRKR Price Target Upside V Benchmarks

TypeNameUpside
StockBruker10.15%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks19.58%

Price Target Trends

1M3M12M
# Anlaysts3610
Avg Price Target$53.33$48.00$50.30
Last Closing Price$45.13$45.13$45.13
Upside/Downside18.17%6.36%11.46%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25256--13
Nov, 25256--13
Oct, 25256--13
Sep, 25256--13
Aug, 25256--13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 10, 2025Wolfe Research$60.00$47.6525.92%32.95%
Dec 09, 2025Goldman Sachs$40.00$46.00-13.04%-11.37%
Nov 20, 2025Redburn Partners$60.00$43.3938.28%32.95%
Nov 04, 2025UBS$43.00$38.7111.08%-4.72%
Nov 04, 2025Barclays$45.00$38.7116.25%-0.29%
Oct 02, 2025Barclays$40.00$34.7215.21%-11.37%
Aug 05, 2025Daniel AriasStifel Nicolaus$40.00$32.0724.73%-11.37%
Aug 04, 2025Luke SergottBarclays$43.00$34.7223.85%-4.72%
Aug 04, 2025Jefferies$60.00$34.7272.81%32.95%
Dec 19, 2024Subbu NambiGuggenheim$72.00$55.7429.17%59.54%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 10, 2025Wolfe ResearchPeer PerformOutperformupgrade
Dec 09, 2025Goldman SachsSellSellinitialise
Nov 04, 2025Cowen & Co.HoldHoldhold
Nov 04, 2025UBSNeutralNeutralhold
Nov 04, 2025BarclaysOverweightOverweighthold
Aug 04, 2025BarclaysOverweightOverweighthold
Apr 24, 2025Cleveland ResearchNeutraldowngrade
Dec 19, 2024GuggenheimBuyinitialise
Dec 05, 2024Goldman SachsSellupgrade
Oct 15, 2024BarclaysOverweightinitialise

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.03$1.83$2.00$2.92$0.76----
Avg Forecast$1.33$2.09$2.32$2.55$2.39$2.68$3.04$3.49$3.76
High Forecast$1.35$2.12$2.33$2.58$2.40$2.73$3.08$3.55$3.82
Low Forecast$1.31$2.06$2.30$2.52$2.38$2.59$2.97$3.41$3.68
Surprise %-22.56%-12.44%-13.79%14.51%-68.20%----

Revenue Forecast

$2B $2B $3B $3B $4B $5B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.99B$2.42B$2.53B$2.96B$3.37B----
Avg Forecast$1.96B$2.40B$2.50B$2.92B$3.35B$3.56B$3.76B$4.02B$4.19B
High Forecast$1.98B$2.42B$2.51B$2.95B$3.39B$3.59B$3.78B$4.02B$4.23B
Low Forecast$1.94B$2.37B$2.48B$2.87B$3.34B$3.54B$3.75B$4.02B$4.11B
Surprise %1.26%0.83%1.20%1.66%0.40%----

Net Income Forecast

$100M $200M $300M $400M $500M $600M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$157.80M$277.10M$296.60M$427.20M$113.10M----
Avg Forecast$148.62M$215.24M$241.59M$427.20M$351.43M$391.14M$445.47M$512.28M$553.96M
High Forecast$178.34M$258.29M$289.91M$512.64M$352.90M$401.21M$453.91M$521.99M$562.22M
Low Forecast$118.89M$172.19M$193.27M$341.76M$349.97M$381.08M$437.03M$502.58M$541.32M
Surprise %6.18%28.74%22.77%--67.82%----

BRKR Forecast FAQ

Is Bruker stock a buy?

Bruker stock has a consensus rating of Hold, based on 32 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 15 Buy, 16 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Bruker is a neutral investment for most analysts.

What is Bruker's price target?

Bruker's price target, set by 32 Wall Street analysts, averages $49.71 over the next 12 months. The price target range spans from $40 at the low end to $60 at the high end, suggesting a potential 10.15% change from the previous closing price of $45.13.

How does Bruker stock forecast compare to its benchmarks?

Bruker's stock forecast shows a 10.15% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (19.58%).

What is the breakdown of analyst ratings for Bruker over the past three months?

  • December 2025: 15.38% Strong Buy, 38.46% Buy, 46.15% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 15.38% Strong Buy, 38.46% Buy, 46.15% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 15.38% Strong Buy, 38.46% Buy, 46.15% Hold, 0% Sell, 0% Strong Sell.

What is Bruker’s EPS forecast?

Bruker's average annual EPS forecast for its fiscal year ending in December 2025 is $2.68, marking a 252.63% increase from the reported $0.76 in 2024. Estimates for the following years are $3.04 in 2026, $3.49 in 2027, and $3.76 in 2028.

What is Bruker’s revenue forecast?

Bruker's average annual revenue forecast for its fiscal year ending in December 2025 is $3.56B, reflecting a 5.76% increase from the reported $3.37B in 2024. The forecast for 2026 is $3.76B, followed by $4.02B for 2027, and $4.19B for 2028.

What is Bruker’s net income forecast?

Bruker's net income forecast for the fiscal year ending in December 2025 stands at $391.14M, representing an 245.84% increase from the reported $113.1M in 2024. Projections indicate $445.47M in 2026, $512.28M in 2027, and $553.96M in 2028.